Precipio (PRPO)

• Market cap: $32.4M
• 1 day: -6.46%
• 5 days: -8.45%
• 1 month: -23.56%
• 3 months: -14.58%
• 6 months: -41.42%
• Year to date: -24.01%
• 1 year: -11.58%
• 5 years: -65.33%
• 10 years: -99.08%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Employees: 71